Literature DB >> 10694446

Differential localization of ICAD-L and ICAD-S in cells due to removal of a C-terminal NLS from ICAD-L by alternative splicing.

K Samejima1, W C Earnshaw.   

Abstract

CAD/CPAN/DFF40 is an apoptotic nuclease that is associated with the regulatory subunit ICAD/DFF in healthy cells. ICAD has two forms, ICAD-L/DFF45 and ICAD-S/DFF35, which are transcribed from a single gene by alternative splicing. They differ at the C-terminus: 70 amino acids of ICAD-L are replaced by 4 different amino acids in ICAD-S. We previously showed that both transfected and endogenous ICAD-L are nuclear; however, the localization of ICAD and CAD remains controversial and an important issue to clarify. Here we present the evidence that ICAD-L is nuclear due to the presence of an autonomous nuclear localization signal located in the C-terminal 20 amino acids. This NLS is missing from ICAD-S, which is distributed throughout the cell. We also showed that a GFP:CAD fusion protein is located in the nucleus of transfected cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694446     DOI: 10.1006/excr.2000.4801

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation.

Authors:  E Sharif-Askari; A Alam; E Rhéaume; P J Beresford; C Scotto; K Sharma; D Lee; W E DeWolf; M E Nuttall; J Lieberman; R P Sékaly
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

2.  The regulation of DNAse activities in subcellular compartments of activated thymocytes.

Authors:  Takuya Nagata; Hiroyuki Kishi; Qin Li Liu; Tadashi Matsuda; Tsuneo Imanaka; Kazuhiro Tsukada; Dongchon Kang; Atsushi Muraguchi
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

3.  Caspase-activated DNase/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures.

Authors:  G Cao; W Pei; J Lan; R A Stetler; Y Luo; T Nagayama; S H Graham; X M Yin; R P Simon; J Chen
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

4.  Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation.

Authors:  Xialu Li; Jin Wang; James L Manley
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

5.  Apoptotic DNA degradation into oligonucleosomal fragments, but not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/CAD endonuclease.

Authors:  Victoria Iglesias-Guimarais; Estel Gil-Guiñon; Gisela Gabernet; Mercè García-Belinchón; María Sánchez-Osuna; Elisenda Casanelles; Joan X Comella; Victor J Yuste
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

6.  The effect of ICAD-S on the formation and intracellular distribution of a nucleolytically active caspase-activated DNase.

Authors:  Sebastian Richard Scholz; Christian Korn; Oleg Gimadutdinow; Michael Knoblauch; Alfred Pingoud; Gregor Meiss
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

7.  Caspases disrupt the nuclear-cytoplasmic barrier.

Authors:  L Faleiro; Y Lazebnik
Journal:  J Cell Biol       Date:  2000-11-27       Impact factor: 10.539

8.  Determinants of the nuclear localization of the heterodimeric DNA fragmentation factor (ICAD/CAD).

Authors:  D Lechardeur; L Drzymala; M Sharma; D Zylka; R Kinach; J Pacia; C Hicks; N Usmani; J M Rommens; G L Lukacs
Journal:  J Cell Biol       Date:  2000-07-24       Impact factor: 10.539

Review 9.  The role of the DFF40/CAD endonuclease in genomic stability.

Authors:  Merve Kulbay; Nathan Bernier-Parker; Jacques Bernier
Journal:  Apoptosis       Date:  2021-01-02       Impact factor: 4.677

10.  Engineered apoptotic nucleases for chromatin research.

Authors:  Fei Xiao; Piotr Widlak; William T Garrard
Journal:  Nucleic Acids Res       Date:  2007-07-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.